Ustekinumab; Injection 45 mg in 0.5 mL single use pre-filled syringe, Injection 90 mg in 1 mL single use pre-filled syringe, Solution concentrate for I.V. infusion 130 mg in 26 mL (5 mg per mL); Epyztek^®

Page last updated: 4 July 2025

• Public Summary Document (PSD) March 2025 PBAC Meeting - (PDF 1MB)
• Public Summary Document (PSD) March 2025 PBAC Meeting - (Word 88KB)